NasdaqGS - Nasdaq Real Time Price USD
Mineralys Therapeutics, Inc. (MLYS)
16.07
+0.37
+(2.36%)
As of 2:26:11 PM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 2,798,939 | 11 |
| Sales | 133,669 | 7 |
| Net Shares Purchased (Sold) | 2,665,270 | 18 |
| Total Insider Shares Held | 948.3k | -- |
| % Net Shares Purchased (Sold) | -155.20% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| RODMAN DAVID MALCOM Officer | Sale at price 15.29 per share. | Direct | 173,774 | May 14, 2025 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 6,857 | May 12, 2025 |
| RODMAN DAVID MALCOM Officer | Sale at price 13.69 - 14.83 per share. | Direct | 165,185 | Apr 14, 2025 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 6,856 | Apr 14, 2025 |
| CONGLETON JON Chief Executive Officer | Sale at price 12.19 per share. | Direct | 186,803 | Apr 11, 2025 |
| LEVY ADAM SCOTT Chief Financial Officer | Sale at price 12.06 per share. | Direct | 129,684 | Apr 11, 2025 |
| RODMAN DAVID MALCOM Officer | Sale at price 13.84 - 16.02 per share. | Direct | 813,359 | Apr 1, 2025 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 1,734 | Apr 1, 2025 |
| RA CAPITAL MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.50 per share. | Indirect | 17,499,996 | Mar 13, 2025 |
| AKKARAJU SRINIVAS Director | Purchase at price 13.50 per share. | Indirect | 8,100,000 | Mar 13, 2025 |
| SLINGSBY BRIAN TAYLOR Director and Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.50 per share. | Indirect | 3,499,996 | Mar 13, 2025 |
| SAMSARA BIOCAPITAL GP, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.50 per share. | Indirect | 8,100,000 | Mar 13, 2025 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 6,857 | Mar 12, 2025 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 6,856 | Feb 12, 2025 |
| CONGLETON JON Chief Executive Officer | Sale at price 9.06 per share. | Direct | 166,082 | Jan 13, 2025 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,567 | Jan 13, 2025 |
| LEVY ADAM SCOTT Chief Financial Officer | Sale at price 9.09 - 9.63 per share. | Direct | 97,864 | Jan 13, 2025 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 per share. | Direct | 2,709 | Dec 11, 2024 |
| RODMAN DAVID MALCOM Officer | Sale at price 15.00 per share. | Direct | 75,398 | Nov 11, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 8,137 | Nov 11, 2024 |
| RODMAN DAVID MALCOM Officer | Sale at price 15.03 per share. | Direct | 383,066 | Nov 6, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 27,521 | Nov 6, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 8,489 | Oct 14, 2024 |
| CONGLETON JON Chief Executive Officer | Sale at price 13.52 per share. | Direct | 206,433 | Oct 11, 2024 |
| LEVY ADAM SCOTT Chief Financial Officer | Sale at price 13.57 per share. | Direct | 146,004 | Oct 11, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,567 | Sep 12, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,565 | Aug 12, 2024 |
| SLINGSBY BRIAN TAYLOR Director and Beneficial Owner of more than 10% of a Class of Security | Sale at price 13.05 per share. | Indirect | 7,177,500 | Jul 24, 2024 |
| RODMAN DAVID MALCOM Officer | Sale at price 15.00 per share. | Direct | 7,876 | Jul 16, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 567 | Jul 16, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,566 | Jul 12, 2024 |
| CONGLETON JON Chief Executive Officer | Sale at price 13.34 per share. | Direct | 210,075 | Jul 11, 2024 |
| LEVY ADAM SCOTT Chief Financial Officer | Sale at price 13.14 per share. | Direct | 141,394 | Jul 11, 2024 |
| CONGLETON JON Chief Executive Officer | Sale at price 11.73 - 12.25 per share. | Direct | 592,022 | Jun 20, 2024 |
| CONGLETON JON Chief Executive Officer | Sale at price 12.52 - 12.77 per share. | Direct | 924,203 | Jun 14, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,566 | Jun 12, 2024 |
| LEVY ADAM SCOTT Chief Financial Officer | Sale at price 12.94 per share. | Direct | 1,252,718 | Jun 11, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,566 | May 13, 2024 |
| RODMAN DAVID MALCOM Officer | Sale at price 15.00 per share. | Direct | 1,500 | May 9, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 1.08 per share. | Direct | 108 | May 9, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,566 | Apr 12, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,565 | Mar 12, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,566 | Feb 12, 2024 |
| RA CAPITAL MANAGEMENT, L.P. Unknown | Stock Award(Grant) at price 13.50 per share. | Indirect | 22,578,858 | Feb 12, 2024 |
| AKKARAJU SRINIVAS Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 13.50 per share. | Indirect | 7,499,992 | Feb 12, 2024 |
| SAMSARA BIOCAPITAL GP, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.50 per share. | Indirect | 7,499,992 | Feb 12, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 - 1.08 per share. | Direct | 9,565 | Jan 12, 2024 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 per share. | Direct | 2,710 | Dec 11, 2023 |
| CONGLETON JON Chief Executive Officer | Purchase at price 5.97 per share. | Direct | 25,356 | Nov 22, 2023 |
| RODMAN DAVID MALCOM Officer | Conversion of Exercise of derivative security at price 0.54 per share. | Direct | 2,709 | Nov 13, 2023 |
Related Tickers
TYRA Tyra Biosciences, Inc.
9.87
+2.81%
TRML Tourmaline Bio, Inc.
18.70
+9.31%
UPB Upstream Bio, Inc.
10.54
-1.17%
TRVI Trevi Therapeutics, Inc.
6.03
-4.59%
CGEM Cullinan Therapeutics, Inc.
9.01
+2.97%
ETNB 89bio, Inc.
10.18
+0.69%
MLTX MoonLake Immunotherapeutics
49.33
+19.85%
ELVN Enliven Therapeutics, Inc.
21.25
+11.02%
KRYS Krystal Biotech, Inc.
131.97
+5.27%
PHVS Pharvaris N.V.
17.84
+8.16%